Samsung Medical Center
| Corea del Sud | Turchia | Austria | |
| Resezione epatica | da $15,800 | da $11,700 | da $35,000 |
| Chemoembolizzazione del fegato | da $4,800 | da $7,500 | da $16,000 |
| Asportazione del tumore al fegato | da $11,550 | da $10,800 | da $40,000 |
| Ablazione con radiofrequenza del fegato | da $6,200 | da $3,500 | da $12,000 |
| Chemioterapia per il cancro al fegato | da $3,000 | da $1,800 | - |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Metastasi epatiche. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Metastasi epatiche e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Metastasi epatiche.
Il medico si è laureato presso il College of Medicine della Seoul National University e ha completato la residenza e il tirocinio presso il Seoul National University Hospital. Ulteriore formazione specialistica è stata intrapresa attraverso una borsa di studio presso l'Università di Pittsburgh in Pennsylvania, USA. Ulteriore istruzione è stata ricevuta presso il College of Medicine dell'Università di Kyoto in Giappone.<\/p>
Il medico è un membro attivo di diverse società accademiche prestigiose, tra cui l'Associazione Medica Coreana, la Società Chirurgica Coreana e la Società Coreana per la Ricerca sul Cancro al Fegato, tra gli altri, evidenziando un focus sulla chirurgia epatobiliare pancreatica.<\/p>
Il dottore è un esperto in chirurgia oncoplastica e cancro al seno, con una vasta esperienza in istituzioni prestigiose. Il dottore possiede una laurea in medicina (M.D.) dal College of Medicine della Seoul National University e un master in chirurgia (M.S.) dalla stessa istituzione. Inoltre, il dottore ha conseguito una laurea in scienze biologiche (B.S.) presso il Korea Advanced Institute of Science and Technology (KAIST) e un dottorato di ricerca (Ph.D.) in chirurgia presso la Graduate School della Seoul National University.<\/p>
Latest treatments for liver metastases in South Korea include living donor liver transplantation, robotic resections, and transarterial radioembolization (TARE). JCI-accredited centers in Seoul utilize multidisciplinary tumor boards. These teams combine targeted immunotherapy with locoregional techniques like radiofrequency ablation to maximize survival rates.
Bookimed Expert Insight: While many countries maintain strict liver transplant criteria, Asan Medical Center reports a 90% success rate with organ transplants. This level of expertise attracts international patients from the USA and UAE. Data shows these top-tier centers manage massive volumes, with Severance Hospital seeing 1.6 million outpatients annually. This high frequency translates to deeper surgical experience for complex metastatic cases.
Patient Consensus: Patients emphasize finding a high-volume center where a multidisciplinary tumor board can determine if lesions are resectable. Many note that local surgeons often use pre-treatment to shrink tumors before attempting removal.
South Korea bietet fortschrittliche nicht-chirurgische Behandlungen für Lebermetastasen an. Patienten erhalten Zugang zu Radiofrequenzablation (RFA), transarterieller Chemoembolisation (TACE) und innovativer Schwerionentherapie. Diese minimalinvasiven Methoden zerstören Tumorgewebe gezielt ohne Skalpell. Onkologische Zentren mit JCI-Akkreditierung nutzen diese Verfahren bei inoperablen Befunden.
Bookimed Expert Insight: Ein signifikanter Trend in Seoul ist die digitale Integration der Patientenpfade. Das Seoul National University Hospital und das Samsung Medical Center behandeln jährlich über 2 Millionen Patienten. Diese enorme Fallzahl ermöglicht es den Onkologen, selbst kleinste Metastasen mittels KI-gestützter Bildgebung für die Ablation präzise zu lokalisieren. Für Patienten bedeutet diese Erfahrung oft eine höhere Erfolgsrate bei technisch schwierigen, nicht-chirurgischen Eingriffen.
Patient Consensus: Patienten betonen oft, dass eine Operation bei multiplen Metastasen nicht immer die beste Lösung ist. Sie empfehlen dringend eine multidisziplinäre Zweitmeinung, um lokale Therapien wie die Ablation mit systemischer Onkologie sinnvoll zu kombinieren.
Top Korean hospitals for liver metastases include Asan Medical Center, Samsung Medical Center, and Seoul National University Hospital. These centers feature specialized hepatobiliary departments. They utilize advanced image-guided radiation and robotic surgery. Most facilities hold JCI or KOIHA accreditations for oncology safety.
Bookimed Expert Insight: Patient volume often signals surgical expertise in Seoul. Asan Medical Center performs over 65,500 operations annually. This high frequency helps surgeons maintain precision in complex liver resections. For digital-first care, Seoul National University Bundang Hospital led as the first fully digitalized facility.
Patient Consensus: Patients note that major Seoul centers prioritize multidisciplinary care. They recommend bringing original pathology slides to speed up the treatment review process.
South Korea provides superior liver-metastases treatment through world-class surgical expertise and specialized multi-modal care. High-volume centers report 5-year survival rates exceeding 90% for specific liver pathologies. Advanced facilities utilize robotic surgery, Da Vinci systems, and chemoembolization to manage complex secondary tumors efficiently.
Bookimed Expert Insight: While many countries offer liver surgery, South Korea stands out for extreme specialization in high-volume oncology. Asan Medical Center performs over 65,000 operations annually, often handling cases others might refuse. This concentration of complex procedures means Korean surgeons refine their techniques much faster than those in lower-volume systems.
Patient Consensus: Patients value the speed of the Korean system, noting that imaging and treatment often begin much faster than in Western countries. International visitors also appreciate the smooth coordination provided by dedicated English-speaking departments in Seoul.